Historically, pharmaceutical companies and governments have argued that the high cost of research and development dictates that there should be strong patent protection, likely to provide incentives for that investment.
Historically, pharmaceutical companies and governments have argued that the high cost of research and development dictates that there should be strong patent protection, likely to provide incentives for that investment.